These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 514257)

  • 1. Molecular basis for the irreversible inhibition of 4-aminobutyric acid:2-oxoglutarate and L-ornithine:2-oxoacid aminotransferases by 3-amino-1,5-cyclohexadienyl carboxylic acid (isogabaculline).
    Metcalf BW; Jung MJ
    Mol Pharmacol; 1979 Sep; 16(2):539-45. PubMed ID: 514257
    [No Abstract]   [Full Text] [Related]  

  • 2. Enzyme-activated irreversible inhibitors of L-ornithine:2-oxoacid aminotransferase. Demonstration of mechanistic features of the inhibition of ornithine aminotransferase by 4-aminohex-5-ynoic acid and gabaculine and correlation with in vivo activity.
    Jung MJ; Seiler N
    J Biol Chem; 1978 Oct; 253(20):7431-9. PubMed ID: 701263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrelationships between ornithine, glutamate, and GABA. II. Consequences of inhibition of GABA-T and ornithine aminotransferase in brain.
    Daune G; Seiler N
    Neurochem Res; 1988 Jan; 13(1):69-75. PubMed ID: 2897088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gabuculine and isogabaculine: in vivo biochemistry and pharmacology in mice.
    Schechter PJ; Tranier Y; Grove J
    Life Sci; 1979 Mar; 24(13):1173-82. PubMed ID: 449617
    [No Abstract]   [Full Text] [Related]  

  • 5. The irreversible inhibition of mouse brain gamma-aminobutyric acid (GABA)-alpha-ketoglutaric acid transaminase by gabaculine.
    Rando RR; Bangerter FW
    J Am Chem Soc; 1976 Oct; 98(21):6762-4. PubMed ID: 972233
    [No Abstract]   [Full Text] [Related]  

  • 6. 3-Mercaptopropionic acid: convulsant properties, effects on enzymes of the gamma-aminobutyrate system in mouse brain and antagonism by certain anticonvulsant drugs, aminooxyacetic acid and gabaculine.
    Löscher W
    Biochem Pharmacol; 1979 Apr; 28(8):1397-407. PubMed ID: 444305
    [No Abstract]   [Full Text] [Related]  

  • 7. [Gamma-aminobutyric acid system in the cat brain during convulsions].
    Snisar' IA; Orekhov VS; Sytinskiĭ IA
    Vopr Med Khim; 1982; 28(5):60-3. PubMed ID: 7179835
    [No Abstract]   [Full Text] [Related]  

  • 8. The in vivo inhibition of GABA-transaminase by gabaculine.
    Rando RR; Bangerter FW
    Biochem Biophys Res Commun; 1977 Jun; 76(4):1276-81. PubMed ID: 901477
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of gabaculine, a new potent inhibitor of gamma-amonobutyrate transaminase, on the brain gamma-amonobutyrate content and convulsions in mice.
    Matsui Y; Deguchi T
    Life Sci; 1977 Apr; 20(7):1291-5. PubMed ID: 850479
    [No Abstract]   [Full Text] [Related]  

  • 10. The inactivation of gamma-aminobutyric acid transaminase in dissociated neuronal cultures from spinal cord.
    Rando RR; Bangerter FW; Farb DH
    J Neurochem; 1981 Mar; 36(3):985-90. PubMed ID: 7205286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme-induced inactivation of transminases by acetylenic and vinyl analogues of 4-aminobutyrate.
    John RA; Jones ED; Fowler LJ
    Biochem J; 1979 Feb; 177(2):721-8. PubMed ID: 435262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyritinol and the enzymes of gamma-aminobutyric acid (GABA) synthesis and degradation.
    Turský T
    Physiol Bohemoslov; 1988; 37(2):135-43. PubMed ID: 2975003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the inhibition of glutamic acid decarboxylase and gamma-aminobutyric acid transaminase by sodium cyanide.
    Cassel G; Karlsson L; Sellström A
    Pharmacol Toxicol; 1991 Oct; 69(4):238-41. PubMed ID: 1956876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of inhibitors of GABA-transaminase for the determination of GABA turnover in mouse brain regions: an evaluation of aminooxyacetic acid and gabaculine.
    Bernasconi R; Maitre L; Martin P; Raschdorf F
    J Neurochem; 1982 Jan; 38(1):57-66. PubMed ID: 7108535
    [No Abstract]   [Full Text] [Related]  

  • 15. Inactivation of pyridoxal phosphate enzymes by gabaculine. Correlation with enzymic exchange of beta-protons.
    Soper TS; Manning JM
    J Biol Chem; 1982 Dec; 257(23):13930-6. PubMed ID: 7142186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo action of enzyme-activated irreversible inhibitors of glutamic acid decarboxylase and gamma-aminobutyric acid transaminase in retina vs. brain.
    Cubells JF; Blanchard JS; Smith DM; Makman MH
    J Pharmacol Exp Ther; 1986 Aug; 238(2):508-14. PubMed ID: 3735130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. gamma-Aminobutyric acid metabolism in rat brain following chronic oral administration of ethanolamine O-sulphate.
    Fletcher A; Fowler LJ
    Biochem Pharmacol; 1980 Jun; 29(11):1451-4. PubMed ID: 7396979
    [No Abstract]   [Full Text] [Related]  

  • 18. Mode of inhibition of ornithine aminotransferase by L-canaline.
    Kito K; Sanada Y; Katunuma N
    J Biochem; 1978 Jan; 83(1):201-6. PubMed ID: 624704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differential effects of GABA-transaminase inactivation in the chick retina and brain.
    Rando RR; Coburn J; Parkinson D
    J Neurochem; 1982 Oct; 39(4):1147-51. PubMed ID: 7119785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo effects on brain GABA metabolism of (S)-4-amino-5-fluoropentanoic acid, a mechanism-based inactivator of gamma-aminobutyric acid transaminase.
    Silverman RB; Muztar AJ; Levy MA; Hirsch JD
    Life Sci; 1983 Jun; 32(24):2717-23. PubMed ID: 6855467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.